Trial design and oversight
This prospective, multicenter, randomized clinical trial was conducted at four centers in China. All patients provided written informed consent before participation, and the institutional review board of each center approved the protocol before the initiation of the study. The coauthors contributed to the first draft of the original manuscript and revision of the original manuscript. This study was registered at 